ETF in Focus: GREK
Health Care: Drugs
Anesiva Incorporated (ANSV: OTC)
$0.02 0.00 | 0.00%
03/23/10 - 03:32 PM ET
35.38K / 912.70K
Vol / Avg. Vol:0.02 / 0.02
Open / Prev. Close:0.02 - 0.03
Today's Range:0.02 - 0.60
52 Wk Range:-86.47%
Performance YTD:TheStreet Rating:
Portfolios with ANSV
- Portfolio NameUser Type
- Usermpress
- Usersnaquimby Portfolio 1
- Usertreneehill's pennies
- UserBarron's Insider Purchases ...
- UserBarron's Research Reports 8...
- Userkeithjones6161 Portfolio 1
- User55 List 1
- Userrobert1903 Portfolio 1
- UserLLLportfolio
- Usercoolwho Portfolio 1
Latest ANSV Headlines from TheStreet
- Zingo Study Results Lift Anesiva 10.16.07 | 10:10 am
- Thursday's Health Winners & Losers 08.30.07 | 03:08 pm
- Friday's Health Winners & Losers 08.17.07 | 05:08 pm
- Anesiva Climbs on FDA OK 08.17.07 | 10:08 am
- Monday's Health Winners & Losers 07.02.07 | 03:07 pm
- Stock Upgrades, Downgrades from TheStreet.com Ratings 06.25.07 | 11:06 am
Press Releases for ANSV
- Anesiva Announces Merger With Arcion Therapeutics Will Not Be Completed - PR Newswire 12.31.09 | 05:12 pm
- Anesiva Completes Sale Of Its Zingo(TM) Assets To Powder Pharmaceuticals And Lee's Pharmaceuticals - PR Newswire 12.09.09 | 05:12 pm
- Anesiva Stockholders Approved Merger With Arcion Therapeutics But Merger Remains Contingent On Other Closing Conditions - PR Newswire 12.08.09 | 06:12 am
- Anesiva Receives NASDAQ Listing Compliance Notice - PR Newswire 12.08.09 | 06:12 am
- Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion Of Proposed Merger - PR Newswire 11.23.09 | 06:11 am
Partner Headlines for ANSV
